192 related articles for article (PubMed ID: 10871063)
1. Mycosis fungoides with CD30-positive cells in the epidermis.
Wu H; Telang GH; Lessin SR; Vonderheid EC
Am J Dermatopathol; 2000 Jun; 22(3):212-6. PubMed ID: 10871063
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
3. The expression of CXCR3 and CD30 in mycosis fungoides.
Nikoo A
Arch Iran Med; 2012 Mar; 15(3):146-50. PubMed ID: 22369302
[TBL] [Abstract][Full Text] [Related]
4. Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma.
Wood GS; Bahler DW; Hoppe RT; Warnke RA; Sklar JL; Levy R
J Invest Dermatol; 1993 Sep; 101(3):296-300. PubMed ID: 8396607
[TBL] [Abstract][Full Text] [Related]
5. CD30 expression and proliferative fraction in nontransformed mycosis fungoides.
Edinger JT; Clark BZ; Pucevich BE; Geskin LJ; Swerdlow SH
Am J Surg Pathol; 2009 Dec; 33(12):1860-8. PubMed ID: 19898220
[TBL] [Abstract][Full Text] [Related]
6. Utility of CD30, Ki-67, and p53 in assisting with the diagnosis of mycosis fungoides with large cell transformation.
Raghavan SS; Hong EK; Kim YH; Kim J
J Cutan Pathol; 2019 Jan; 46(1):33-43. PubMed ID: 30328119
[TBL] [Abstract][Full Text] [Related]
7. Correlations between clinical and pathological features in 17 cases of mycosis fungoides before and after transformation.
Bittencourt AL; Oliveira PD; Carvalho-Andrade A; Araújo I
Int J Dermatol; 2015 Sep; 54(9):e327-31. PubMed ID: 26147565
[TBL] [Abstract][Full Text] [Related]
8. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
9. A review of CD30 expression in cutaneous neoplasms.
Kampa F; Mitteldorf C
J Cutan Pathol; 2021 Apr; 48(4):495-510. PubMed ID: 33047376
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides with spontaneously regressing CD30-positive tumorous lesions.
Woodrow SL; Basarab T; Russell Jones R
Clin Exp Dermatol; 1996 Sep; 21(5):370-3. PubMed ID: 9136160
[TBL] [Abstract][Full Text] [Related]
11. Impressive response of CD30-negative, treatment-refractory mycosis fungoides to brentuximab vedotin.
Goyal A; Hordinsky M; Lazaryan A
Dermatol Ther; 2019 Mar; 32(2):e12835. PubMed ID: 30659762
[TBL] [Abstract][Full Text] [Related]
12. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
Eberle FC; Song JY; Xi L; Raffeld M; Harris NL; Wilson WH; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2012 May; 36(5):716-25. PubMed ID: 22367293
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in 105 Japanese cases of mycosis fungoides and Sézary syndrome: clusterin expression as a novel prognostic factor.
Tobisawa S; Honma M; Ishida-Yamamoto A; Saijo Y; Iizuka H
J Dermatol Sci; 2013 Sep; 71(3):160-6. PubMed ID: 23702390
[TBL] [Abstract][Full Text] [Related]
14. Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.
Kim YH; Tavallaee M; Sundram U; Salva KA; Wood GS; Li S; Rozati S; Nagpal S; Krathen M; Reddy S; Hoppe RT; Nguyen-Lin A; Weng WK; Armstrong R; Pulitzer M; Advani RH; Horwitz SM
J Clin Oncol; 2015 Nov; 33(32):3750-8. PubMed ID: 26195720
[TBL] [Abstract][Full Text] [Related]
15. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
[TBL] [Abstract][Full Text] [Related]
16. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
17. The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma.
Gao C; McCormack CJ; van der Weyden C; Twigger R; Buelens O; Lade S; Khoo C; Campbell BA; Goh M; McKelvie P; Prince HM
J Am Acad Dermatol; 2021 Jan; 84(1):185-187. PubMed ID: 32334059
[No Abstract] [Full Text] [Related]
18. Mycosis fungoides with epidermal mucinosis: a variant of mycosis fungoides with a spongiosis-like pattern.
Hu SW; Ratech H; Naeem R; Latkowski JA; Kamino H
J Cutan Pathol; 2015 Oct; 42(10):730-8. PubMed ID: 26009972
[TBL] [Abstract][Full Text] [Related]
19. Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis.
Kim YH; Prince HM; Whittaker S; Horwitz SM; Duvic M; Bechter O; Sanches JA; Stadler R; Scarisbrick J; Quaglino P; Zinzani PL; Wolter P; Eradat H; Pinter-Brown LC; Ortiz-Romero PL; Akilov OE; Trotman J; Taylor K; Weichenthal M; Walewski J; Fisher D; McNeeley M; Gru AA; Brown L; Palanca-Wessels MC; Lisano J; Onsum M; Bunn V; Little M; Trepicchio WL; Dummer R
Eur J Cancer; 2021 May; 148():411-421. PubMed ID: 33794441
[TBL] [Abstract][Full Text] [Related]
20. Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases.
Fauconneau A; Pham-Ledard A; Cappellen D; Frison E; Prochazkova-Carlotti M; Parrens M; Dalle S; Joly P; Viraben R; Franck F; Ingen-Housz-Oro S; Giacchero D; Jullié ML; Vergier B; Merlio JP; Beylot-Barry M
Br J Dermatol; 2015 Jun; 172(6):1547-1554. PubMed ID: 25645336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
